On Thursday (November 13), Canadian Prime Minister Mark Carney announced a second round of nation-building projects that will be referred to the Major Projects Office. The office was established earlier…
Investing
-
-
During the Mining Share panel at the New Orleans Investment Conference, participants underscored that the gold bull market will continue — however, just where we are in that bull run…
-
Cyprium Metals (CYM:AU) has announced Senior Loan Facility Refinanced with Nebari Download the PDF here. This post appeared first on investingnews.com
-
Investing
Locksley Resources LimitedAppointment of Experienced Geologist Ian Stockton to Board
by adminPerth, Australia (ABN Newswire) – Locksley Resources Ltd (ASX:LKY,OTC:LKYRF) (FRA:X5L) (OTCMKTS:LKYRF) announced the appointment of Mr Ian Stockton as Non-Executive Technical Director with effect from immediately following the AGM on…
-
Peter Schiff, chief economist and global strategist at Euro Pacific Asset Management and founder of Schiff Gold, shares his outlook on gold and silver prices. He also discusses Bitcoin and…
-
Chris Marcus, founder of Arcadia Economics, shares his thoughts on silver and gold. While it’s impossible to know exactly how precious metals prices will move in the short term, he’s…
-
Jordan Roy-Byrne, CMT, MFTA, editor and publisher of the Daily Gold, discusses how long the gold and silver correction could last, and how high prices could go once it’s over.…
-
Is gold’s price pullback a buying opportunity, or the end of its run? Omar Ayales of Gold Charts R Us weighs in, saying either scenario is possible. He’s watching factors…
-
Investor Insight Executing a well-defined project development strategy for its lithium assets and advancing Direct Lithium Extraction (DLE), CleanTech Lithium is poised to become a key player in the supply…
-
Investing
InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value
by adminInMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors rare small-cap biotech exposure to high-impact…